Stockguru.com: Morning Alerts for Friday, July 11, 2008 include PNGB, ICPR, CLXS, ETLO, and NWCI

Dallas, Texas, Jul 11, 2008 (M2 PRESSWIRE via COMTEX) -- PNGB | Quote | Chart | News | PowerRating -- StockGuru Morning Alerts have been issued for NewCardio, Inc. (OTCBB NWCI), Etelos, Inc. (OTCBB:ETLO), Collexis Holdings Inc. (OTCBB CLXS), ICP Solar Technologies Inc. (OTCBB ICPR), and Panglobal Brands Inc. (OTCBB PNGB). StockGuru Morning Alerts feature the biggest net gainers. In our update we analyze recent news about the companies featured and detail the movement in the stock.

If you would like to feature your publicly traded company in our alerts or on StockGuru, email john@stockguru.com or call (469)252-3030.

Panglobal Brands Inc. (OTCBB PNGB | Quote | Chart | News | PowerRating) Thursday's market went down 10.61% to $59 per share, with a total of 43,350 shares traded. The Company will record its best quarterly sales revenue in its history, growing 85% over March 31, 2008. Sales revenue for the three months ended June 30, 2008 totaled $5,500,000 versus sales revenue of $ 2,963,000 for the three months ended March 31, 2008. Year to date sales revenue for the nine months ended June 30, 2008 totaled $8,584,000 versus $382,000 for the nine months ended June 30, 2007. Panglobal Brands Inc. currently has sales orders totaling $9,100,000, for deliveries to retail stores in its order backlog. Scrapbook accounts for $3,400,000 of that total and SoSik and our contemporary divisions account for the balance of $5,700,000. Most of the order backlog is intended to be shipped during the four months to October 31st. Our strategy has been to build a series of apparel brands, consisting of mainly women's apparel, and to build brand recognition by marketing our products to fashion conscious consumers who shop in boutiques and department stores and who want to wear and be seen in the latest and most fashionable clothing and accessories. Our SoSik junior business has been our biggest seller this year and has recorded sales of over $4,000,000 for the quarter ended June 30, 2008 while building some major customer relationships including Charlotte Russe, Buckle and Forever 21. Under the SoSik label, we design and market junior denim, t-shirts, dresses and sportswear. Our success in the juniors' business has reflected our ability to continually keep the products new, fresh and part of what is in fashion.

Panglobal Brands, Inc. is committed to building a diverse stable of apparel brands, capitalizing on opportunities to participate in the hottest fashion trends as they happen. Our business strategy is to create a balance with dynamic branded products and the traditionally more stable private label apparel business by selling branded products through specialty retailers and by running a private label division catering to department store chains. Our current brands include: Mynk, a high-end, high-fashion denim brand selling at specialty retailers and Saks 5th Avenue; Nela, an upscale contemporary print dress label; Tea & Honey, a casual ladies wear collection that's ready to burst onto the scene later this year; SoSik, which represents affordable fashions for the burgeoning junior market; and Scrapbook, which is aimed at the teen and junior markets and features mix and match knits.

For a quote and the latest news on this company, please visit: http://smallcapbull.com/quotes/PNGB.php.

ICP Solar Technologies Inc. (OTCBB ICPR | Quote | Chart | News | PowerRating) Thursday's market went up 12.73% to $62 per share, with a total of 4,585 shares traded. The Company announced a new contract with Pro Sport, a major Automotive distributor in Russia and Ukraine. Pro Sport is one of the leading distributors, which offers the largest selection of Auto and Car parts of the Russian and Ukrainian Automotive After market. The Eastern population is becoming more and more interested in worldwide brands. Plug and play solar chargers for Russian and Ukrainian cars, campers and boats make senses which includes nowadays more and more electronic such as GPS, Blackberry and Cell phones, stated Pascal Petit, ICP Solar's VP of Sales- Europe and Asia Pacific. This is a market where upscale people are very aware of their environment and have quickly embraced the use of mobile alternative energy, so the demand for our solar charger solutions will be high. We are thrilled to be working with Pro Sport in order to be able to provide to vehicle lovers our Sunsei SE 150, Sunsei SE 500 and our unique Solar grip products, for the first time in these markets.

ICP Solar is a developer, manufacturer and marketer of solar panels and solar cell based products and building materials. Through the application of next-generation technologies and use of proprietary intellectual design the Company aims to be the industry's innovation leader. For the past 19 years, ICP Solar has led the consumer market through innovation and has now begun to apply that same philosophy to the OEM, rooftop and power generation segment of the solar industry. ICP Solar's management has over 50 years of experience in the renewable energy sector. ICP Solar is the North American licensee of the Coleman brand in the solar charger category. The company's headquarters are located in Montreal, Canada, with additional locations in the USA, Spain, Ireland and France.

For a quote and the latest news on this company, please visit: http://smallcapbull.com/quotes/ICPR.php.

Collexis Holdings Inc. (OTCBB CLXS | Quote | Chart | News | PowerRating) Thursday's market went down 2.13% to $46 per share, with a total of 38,000 shares traded. The Company announced that the National Center for Research Resources (NCRR), of the National Institutes of Health (NIH), has chosen the company to develop a State of Science Analysis System to help better direct funding for biomedical technology research. NCRR provides clinical and translational researchers with resources to understand, detect, treat and prevent a wide range of diseases. Because the answers to complex questions are not contained in single documents, NCRR must look across its entire grant portfolio to determine the best use of funding for resources. Traditional search technologies are not very useful for making this kind of analysis. Using ground-breaking technology from Collexis called Portfolio Analysis, NCRR will be able to compare the specific technologies it has funded to the state of science as represented in scientific journals and unfunded grant portfolios. This will enable NCRR to decide if it is funding research in the most promising technologies or overfunding some areas. It will also help identify gaps or blind spots where specific areas of research might be underfunded.

Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world's first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined fingerprinted concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as finding needles in many haystacks. Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.

For a quote and the latest news on this company, please visit: http://smallcapbull.com/quotes/CLXS.php.

Etelos, Inc. (OTCBB:ETLO) Thursday's market went up 20.00% to $900 per share, with a total of 21,057 shares traded. Eventbrite.com, the leading self-service online event management and registration site, and the Company announced a joint partnership to bring a custom Eventbrite storefront to the Etelos Marketplace. With the addition of Eventbrite, Etelos continues to demonstrate how the Etelos Marketplace is the place for small and medium-sized businesses and enterprise users to shop for Web-based business and productivity solutions. Eventbrite's business solution simplifies the registration and marketing of events and seminars. We are delighted to be a part of the Etelos Marketplace, said Jack Mardack, Eventbrite's director of marketing. Etelos caters to businesses looking for ways to operate better, smarter and more profitably using Web-based applications. This is a great place for Eventbrite."

Etelos, Inc. provides software productivity solutions that assist organizations to use Web applications. It also provides a software-as-a-service ecosystem for building, distributing, and using Web applications, including a marketplace to deploy and support them; and giving businesses choices in applications, hosting, and support services to accomplish goals. The company develops products for Web applications, which include open standards-based tools for Web developers, businesses, and individual users, such as the Etelos Application Server and the Etelos Development Environment that supports various common programming languages; and the English Application Scripting Engine, a scripting language developed by the company. Its marketplace supports and encourages communities of developers, distributors, and consumers to expand their offerings, collaborate on new ideas and improvements, and provide scalable solutions using Web applications available to others. Etelos, Inc. was incorporated in 1999 and is based in Fremont, California.

For a quote and the latest news on this company, please visit: http://smallcapbull.com/quotes/ETLO.php.

NewCardio, Inc. (OTCBB NWCI | Quote | Chart | News | PowerRating) Thursday's market went up 0.82% to $368 per share, with a total of 15,600 shares traded. The Company revealed the results of its second external validation study of QTinno (the NCE2 Study), its third and largest clinical validation study to date. The study was led by an independent industry leading cardiac safety expert with extensive experience in pharmaceutical clinical trials. As was the case in NewCardio's earlier clinical validation trials, the NCE2 study evaluated the accuracy, precision and speed of NewCardio's lead product, QTinno, in producing fully automated measurements of drug-induced QT prolongation, a key cardiac safety indicator. Such data is now required by drug regulatory bodies worldwide for all new drugs in development, and at present must be obtained by expensive and time-consuming manual or semi-automated methods. The NCE2 study was a randomized, blinded study of more than 7,000 digital ECGs acquired from healthy research subjects treated with placebo and two doses of a drug known to have modest QT-prolonging properties. QT intervals were determined on all 7,000 ECGs by QTinno and by the current gold standard approach: careful manual reading by a single cardiologist with extensive expertise and experience in ECG evaluation. The primary endpoint, time-matched, placebo-controlled QT prolongation induced by drug, was chosen because drug-induced QT prolongation is the primary parameter that regulatory bodies evaluate to assess the cardiac arrhythmia risk of a new drug candidate.

NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology to provide higher accuracy to, and increase the value of, the standard 12-lead electrocardiogram (ECG). NewCardio's development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease (CVD), as well as cardiac safety assessment of drugs under development. NewCardio's three-dimensional ECG platform is designed to reduce the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. For more information, visit www.newcardio.com.

For a quote and the latest news on this company, please visit: http://smallcapbull.com/quotes/NWCI.php.

About the StockGuru Community:

The StockGuru Community is a leading industry news, investor and research resource portal covering the smallcap markets every day. To join our community, please visit: http://www.stockguru.com. Membership is always free.

To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3030. Our services include customized investor awareness programs on StockGuru.com, video presenations on ShareholderVision.com, and a range of services on QuarterbackIR.com.

StockGuru is a Pentony Enterprises company. We provide our members with the latest news, press releases, and research reports for all the companies highlighted on the site. StockGuru utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SCB to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. StockGuru encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockGuru makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SCB is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.stockguru.com or mentioned herein.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements.

CONTACT: John Pentony, Publisher, StockGuru Tel: +1 469 252 3030 e-mail: john@stockguru.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index